Category: Finance
-
Grant for Research on Drugs to Improve Tissue Transplants
27 June 2016. Department of Defense is funding research on new drugs that aim to improve the quality of tissue and limbs for transplants donated from people whose brains stop working. DoD awarded the grant of nearly $1 million to the Institute for Transformative Molecular Medicine at Case Western Reserve University School of Medicine in…
-
Genome Editing Company Adds $38M in Venture Funds
Crispr Therapeutics, a company creating treatments for disease that edit the human genome, is raising another $38 million in its second venture financing round.
-
Immunotherapy Company Raises $70 Million in IPO
Selecta Biosciences, a biotechnology company developing treatments harnessing the immune system, is raising $70 million in its initial public offering.
-
Biomaterials Solutions Studied for Chronic Wounds
3 June 2016. A team of materials and medical scientists is investigating a new process of applying protein-based biomaterials to the healing of chronic wounds. The research led by materials scientists Millicent Sullivan and Kristi Kiick at University of Delaware in Newark is funded by a 4 year, $1.4 million grant from National Institute of…
-
Venture Firm Funding Univ. Blood Diagnostics Technology
23 May 2016. A life sciences venture capital company is funding development of a technology at an Israeli research lab using DNA from blood tests to diagnose a range of diseases. Aurum Ventures is providing $1.2 million to Hebrew University of Jerusalem, through its technology transfer affiliate Yissum Research Development Company, for the university lab…
-
Portable Genome Device to Combat Wildlife Trafficking
12 May 2016. A handheld device for analyzing DNA can be used on the scene to identify products with endangered wildlife, to help stop poachers and smugglers of those species. A team from University of Leicester in the U.K. that devised this solution is the recipient of a $10,000 prize in the Wildlife Crime Tech…
-
Neurological Biotech Raises $65M in Venture Funds
10 May 2016. A biotechnology company designing treatments for neurological disorders caused by rigidity in nerve cell synapses, is raising $65 million in its first venture funding round. Aptinyx Inc. in Evanston, Illinois, is a spin-off enterprise that formed when Naurex Inc., another biotech company, was acquired by drug maker Allergan plc in September 2015.…
-
Genome-Editing Company Raises $108 Million in IPO
6 May 2016. Intellia Therapeutics, a developer of therapies based on genome editing, issued its initial public stock offering, raising $108 million. The Cambridge, Massachusetts enterprise, less than 2 years old, issued 6 million shares priced at $18.00. At the 4:00 pm ET closing bell today, company shares trading on the NASDAQ exchange as NTLA…
-
Challenge Seeks New Regenerative Tools with Stem Cells
29 April 2016. A challenge offered through InnoCentive is seeking new methods of harnessing adult stem cells for regenerative medicine. The competition has a total purse of $15,000 and a 24 June 2016 deadline for submissions. The sponsor of the challenge, pharmaceutical company Boehringer Ingelheim, also seeks research plans related to the challenge proposals, with…
-
University Lab Spins-Off Fertility Testing Company
29 April 2016. A new company is taking shape that aims to make it easier for women to get pregnant, based on research at a biochemistry lab at University of Wisconsin. BluDiagnostics, in Madison, founded by postdoctoral research Katie Brenner in the lab of biochemistry professor Douglas Weibel, a co-founder of the company, already raised…